Jan/Feb 2026 • PharmaTimes Magazine • 3
Hello dear reader and a warm welcome to the second quarter of the millennium. How on earth did we get here? Who knows, but proceed we must.
Each year in our industry we are duty bound to leap into whatever happens to be in front of us. We somersault or we tentatively edge into the transformational avenues and, indeed, life-affirming alleyways of the life sciences. Lives are at stake and we run towards the danger – it was always thus.
This time, however, there seem to be greater possibilities and – equally – increased jeopardy. A leap of faith is necessary; a leap into the unknown is compulsory (cue heartbeat sound effect, accompanied by tension music).
With digital medicine and AI drug development comes great curiosity but, by incorporating it, by empowering it, we must accept greater responsibility. Crikey, this is deep for the first edition – but, make no mistake, our laser focus, especially when it comes to the neo-med universe, is non-negotiable.
Needing to trusting the robots is a real thing to wrestle with, and it’s a challenge that is never ending or beginning (on an ever-spinning wheel), such is the human nature woven into the fabric of machine learning.
And, in that respect, this latest plot point in the pharma/healthcare narrative is precisely the same as the first laboratory, the first therapies, the first practitioners, the first national health service. It is nothing if not a projection of ourselves – for worse or for better.
Don’t have nightmares,
John Pinching
editor
PharmaTimes Media Ltd,
44 Maiden Lane
Covent Garden
London
WC2E 7LN
Tel: +44 (0)20 7240 6999
www.pharmatimes.com
Twitter: @PharmaTimes
MAGAZINE
John Pinching / editor
john.pinching@pharmatimes.com
Michelle Legrand / sales manager
michelle.legrand@pharmatimes.com
COMPETITIONS
Luci Sargood / business manager
luci.sargood@pharmatimes.com
Michelle Legrand / sales manager
michelle.legrand@pharmatimes.com
James Tansill / Marketing Executive
james.tansill@pharmatimes.com
PMGROUP
Tara Lovegrove / business director
tara.lovegrove@pharmatimes.com
Iona Everson / group managing editor
iona.everson@pharmatimes.com
Karl Equi / executive director
karl.equi@pharmatimes.com
SUBSCRIPTIONS/REPRINTS
Digital and paper copies available
free to qualifying readers:
www.pharmatimes.com/subscribe
Tel: 01372 414 222
subscriptions@pharmatimes.com
Paper subscriptions available at £90.00 UK
and £100.00 overseas per annum.
Views expressed by the contributors
do not necessarily represent those of
the publisher, editor or staff.
Material may not be reproduced in any form
without the publisher’s written permission.
© Copyright 2025 PharmaTimes Magazine.
All rights reserved. PharmaTimes Magazine
is published by PharmaTimes Media Ltd,
which is registered as a limited company
in England; No 09019637.